ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

University of California appeals CRISPR patent setback – STAT

Continue reading

2017-04-13 Michael Zand NEWS

Dr. Gomella on Ongoing Trials of Immunotherapy in Bladder Cancer – OncLive

OncLiveDr. Gomella on Ongoing Trials of Immunotherapy in Bladder CancerOncLiveLeonard Gomella, MD, professor, chair, Department of Oncology, director, Kimmel Cancer Center Network, Thomas Jefferson University Hospital, discusses ongoing trials of immun… Continue reading

2017-04-13 Michael Zand NEWS

Gene-Editing Alternative Corrects Duchenne Muscular Dystrophy – Drug Discovery & Development


STAT

University of California appeals CRISPR patent setback
STAT
In that decision, the US Patent Trial and Appeal Board ruled that CRISPR patents issued to the Broad Institute of MIT and Harvard in 2014 did not cover the same inventions for which UC had sought patents. The PTAB decision found that the claims can be …
UC Berkeley challenges decision that CRISPR patents belong to Broad InstituteThe Verge
News UC Berkeley, U Vienna, Charpentier Appea…Genetic Engineering & Biotechnology News
UC appeals US patent board decision on CRISPR-Cas9UC Berkeley
Gizmodo –The Atlantic –GlobeNewswire (press release)
all 43 news articles »
Continue reading

2017-04-13 Michael Zand NEWS

Gene therapy company Tocagen prices offering at low end of range – MarketWatch

Gene therapy company Tocagen prices offering at low end of rangeMarketWatchTocagen Inc. TOCA, +0.00% a cancer-selective gene therapy company, said Thursday that it priced its initial public offering at $10 a share, at the low end of its expected range… Continue reading

2017-04-13 Michael Zand NEWS

Spray-On Skin: ‘Miracle’ Stem Cell Treatment Heals Burns Without Scarring – Newsweek


Gizmodo

Gene-Editing Alternative Corrects Duchenne Muscular Dystrophy
Drug Discovery & Development
Using the new gene-editing enzyme CRISPR–Cpf1, researchers at UT Southwestern Medical Center have successfully corrected Duchenne muscular dystrophy in human cells and mice in the lab. The UT Southwestern group had previously used …
A New Flavor of CRISPR Could Tackle Some of the Worst Genetic DiseasesGizmodo
CRISPR Corrects Duchenne-Causing MutationsThe Scientist
Accurate DNA misspelling correction methodPhys.Org
Civil Eats
all 34 news articles »
Continue reading

2017-04-13 Michael Zand NEWS

Fibrocell to Present at 7th Annual World Orphan Drug Congress USA 2017 and 5th Annual Cell & Gene Therapy … – GlobeNewswire (press release)

Fibrocell to Present at 7th Annual World Orphan Drug Congress USA 2017 and 5th Annual Cell & Gene Therapy …GlobeNewswire (press release)EXTON, Pa., April 13, 2017 (GLOBE NEWSWIRE) — Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company f… Continue reading

2017-04-13 Michael Zand NEWS

BRIEF-Crispr, Intellia, Caribou Biosciences, ERS Genomics announce appeal of CRISPR/CAS9 US patent board … – Reuters


Newsweek

Spray-On Skin: ‘Miracle’ Stem Cell Treatment Heals Burns Without Scarring
Newsweek
The treatment, developed by German researcher Dr. Jörg Gerlach, was the world’s first to use a patient’s stem cells to directly heal the skin. If successful, the device would mend Uram’s wounds using his body’s ability to regenerate fully functioning skin.

Continue reading

2017-04-13 Michael Zand NEWS

Mourning Loss of Stem Cell Sister in Moscow HSCT Center – Multiple Sclerosis News Today

Multiple Sclerosis News TodayMourning Loss of Stem Cell Sister in Moscow HSCT CenterMultiple Sclerosis News TodaySadly, Kristen Dyson, who had been giving updates of her progress on Facebook, suffered a serious and rare reaction after her first day of … Continue reading

2017-04-13 Michael Zand NEWS
  • 1
  • …
  • 1,851
  • 1,852
  • 1,853
  • 1,854
  • 1,855
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

BRIEF-Crispr, Intellia, Caribou Biosciences, ERS Genomics announce appeal of CRISPR/CAS9 US patent board …
Reuters
Reuters is the news and media division of Thomson Reuters. Thomson Reuters is the world’s largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news …